Intelligent Ultrasound Group PLC Contingent Liability Update (4285U)
25 Novembre 2019 - 08:00AM
UK Regulatory
TIDMMED
RNS Number : 4285U
Intelligent Ultrasound Group PLC
25 November 2019
Intelligent Ultrasound Group plc
("Intelligent Ultrasound" or the "Company" or the "Group")
The information contained within this announcement is deemed by
the Company to constitute inside information as stipulated under
the Market Abuse Regulations (EU) No. 596/2014. Upon the
publication of this announcement via a Regulatory Information
Service ("RIS"), this inside information is now considered to be in
the public domain.
Contingent Liability Update
Intelligent Ultrasound Group (AIM: MED), the intelligent
ultrasound software and simulation company, is pleased to announce
that HMRC has informed the Group that it will not be seeking
repayment of R&D tax credits paid to its subsidiary,
Intelligent Ultrasound Limited ("IUL"), for the periods ended 14
June 2013 through to 30 September 2016.
In early 2019, the Group was made aware of a potential
over-claim of R&D tax credits made by IUL in the above periods
which were prior to its acquisition by the Company and consequently
made full disclosure of this matter to HMRC. The potential amount
that IUL could have been asked to repay was noted as a contingent
liability in the Group's annual report and accounts for the year
ended 31 December 2018 and in its half yearly report to 30 June
2019. In light of the information now received from HMRC, the
Company believes that there is no longer a liability, contingent or
actual, in respect of this potential over-claim of R&D tax
credits.
Enquiries:
Intelligent Ultrasound Group plc www.intelligentultrasound.com
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Wilson Jennings, Group Finance Director
Cenkos Securities - Nominated Advisor Tel: +44 (0)20 7397 8900
and broker
Giles Balleny / Cameron MacRitchie (Corporate
Finance)
Michael Johnson / Julian Morse (Sales)
Walbrook PR Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com
Anna Dunphy / Paul McManus Mob: +44 (0)7876 741 001 / Mob: +44
(0)7980 541 893
About Intelligent Ultrasound Group
Intelligent Ultrasound (AIM: MED) develops artificial
intelligence-based clinical image analysis software tools for the
diagnostic medical ultrasound market and hi-fidelity virtual
reality simulators for the ultrasound training market.
Based in Cardiff and Oxford in the UK, Atlanta in the US and
with representation in Beijing in Asia, the Group operates two
divisions:
Clinical AI Division
Focusses on developing deep learning-based algorithms to make
ultrasound machines smarter and more accessible. Products in
development include ScanNav which uses machine-learning based
algorithms to automatically identify and grade ultrasound images to
provide scan assessment and audit of protocol-based ultrasound
scanning; and ScanNav AnatomyGuide, which aims to simplify
ultrasound-guided needling by providing the user with real-time
AI-based needle guidance software for a range of medical
procedures.
Simulation Division
Focusses on hi-fidelity ultrasound education and training
through simulation. Its three main products are the ScanTrainer
OBGYN training simulator, the HeartWorks echocardiography training
simulator and the BodyWorks Eve Point of Care and Emergency
Medicine training simulator. To date over 800 simulators have been
sold to almost 500 medical institutions around the world.
www.intelligentultrasound.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
UPDPGGMPGUPBGQP
(END) Dow Jones Newswires
November 25, 2019 02:00 ET (07:00 GMT)
Grafico Azioni Intelligent Ultrasound (LSE:IUG)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Intelligent Ultrasound (LSE:IUG)
Storico
Da Mar 2023 a Mar 2024